Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AstraZeneca PLC

Market Cap 275B 237B 218B 205B 385B 26,001B 388B 2,580B 1,008B 12,733B 1,032B 1,011B 44,060B P/E Ratio 2026 *
22.2x
P/E Ratio 2027 * 19.4x
Enterprise Value 294B 254B 234B 219B 411B 27,820B 416B 2,760B 1,078B 13,624B 1,105B 1,081B 47,142B EV / Sales 2026 *
4.65x
EV / Sales 2027 * 4.28x
Free-Float
96.63%
Yield 2026 *
1.88%
Yield 2027 * 1.99%
1 day+0.25%
1 week-3.19%
Current month-2.48%
1 month-2.85%
3 months-6.83%
6 months-0.71%
Current year-1.97%
1 week 1,658
Extreme 1658
1,744.5
1 month 1,601.5
Extreme 1601.5
1,775.5
Current year 1,601.5
Extreme 1601.5
1,925.5
1 year 1,316
Extreme 1316
1,925.5
3 years 1,226
Extreme 1226
1,925.5
5 years 960.3
Extreme 960.3
1,925.5
10 years 456.8
Extreme 456.8
1,925.5
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Operating Officer 55 01/06/2015
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-3.19% - - 275B
+0.19%-1.77%+39.23%+151.14% 1,007B
-0.62%-1.54%+50.33%+42.08% 567B
-0.10%-2.18%+15.53%+59.05% 392B
-0.23%+1.05%+20.91%+18.37% 328B
-0.29%+0.61%+23.59%+31.23% 277B
-1.58%+3.90%-43.79%-49.27% 196B
+0.16%+1.44%+18.25%+52.19% 189B
+2.37%+0.14%+13.39%+59.36% 154B
+0.10%+1.07%+6.45%-35.16% 148B
Average -0.02%+0.97%+15.99%+36.55% 362.12B
Weighted average by Cap. -0.09%+0.40%+26.21%+66.90%

Financials

2026 *2027 *
Net sales 63.32B 54.58B 50.23B 47.12B 88.51B 5,984B 89.4B 594B 232B 2,931B 238B 233B 10,141B 67.16B 57.88B 53.27B 49.98B 93.88B 6,347B 94.81B 630B 246B 3,108B 252B 247B 10,755B
Net income 12.49B 10.76B 9.91B 9.29B 17.46B 1,180B 17.63B 117B 45.75B 578B 46.86B 45.87B 2,000B 14.14B 12.18B 11.21B 10.52B 19.76B 1,336B 19.96B 133B 51.79B 654B 53.05B 51.93B 2,264B
Net Debt 19.25B 16.59B 15.27B 14.32B 26.9B 1,819B 27.17B 180B 70.5B 891B 72.22B 70.69B 3,082B 12.01B 10.35B 9.52B 8.93B 16.78B 1,135B 16.95B 113B 43.98B 556B 45.05B 44.1B 1,923B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
16/06/26 1,671.00 kr +0.09% 156,840
15/06/26 1,669.50 kr -1.45% 508,660
12/06/26 1,694.00 kr -1.71% 440,089
11/06/26 1,723.50 kr +0.64% 243,357
10/06/26 1,712.50 kr -0.72% 252,423
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
177.38USD
Average target price
221.03USD
Spread / Average Target
+24.61%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!